Fundamentals of Anticancer Therapy Day 2 - Enduring Material - Credit offering period - March 19, 2026 - December 31, 2026
Review Take- Home Work
Mary E. Kern, MSN, RN, OCN, CHSE
*treatment/symptom management
Molecular Targeted Therapies and Immunotherapy
Jeremy Pappacena, PharmD, BCOP
Jennifer Niccolai, PharmD, BCOP
*treatment/symptom management
Hormone Therapy
Heather Kennihan MSN, RN, OCN
*treatment/symptom management
GI Toxicities and Assessment
Mary E. Kern, MSN, RN, OCN, CHSE
*treatment/symptom management
Treatment - BSA, ANC, Calvert, Mosteller
Mary E. Kern, MSN, RN, OCN, CHSE
*treatment
Additional Information
| Attachment | Size |
|---|---|
| 3.62 MB | |
| 21.74 MB | |
| 2.22 MB |
Course summary
- 4.25 AMA PRA Category 1 Credit™
- 4.25 Contact Hours
- 4.25 NCPD
Allegheny Health Network is approved as a provider of nursing continuing professional development by Pennsylvania State Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.
Accreditation: Allegheny General Hospital is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Allegheny General Hospital designates this enduring material activity for a maximum of 5.75 AMA PRA Category 1 Credits ™. Physicians should claim only the credit commensurate with the extent of their participation in this activity.
Allegheny Health Network is approved as a provider for nursing continuing professional development by Pennsylvania State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation
Available Credit
- 4.25 AMA PRA Category 1 Credit™
- 4.25 Contact Hours
- 4.25 NCPD
Allegheny Health Network is approved as a provider of nursing continuing professional development by Pennsylvania State Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.

Facebook
X
LinkedIn
Forward